SCHEMBL6429832

SCHEMBL6429832

CC#CC(CCC)NC(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.38
AKR1A1 P14550 1/20 0.38
CHRM3 P20309 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
ADRA1A P35348 1/20 0.38
HRH1 P35367 1/20 0.38
DRD3 P35462 1/20 0.38
SLC6A3 Q01959 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HDAC7 Q8WUI4 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
CYP3A4 P08684 2/20 0.32
TSHR P16473 2/20 0.32
NFKB1 P19838 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17110972 0.83 FFAR1 (0.32) POLBFFAR1
SCHEMBL17091717 0.82 CHRM1 (0.34) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL168929 0.81 CHRM1 (0.33) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL7998696 0.79 CTSS (0.42) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL27786016 0.77 CTSK (0.34) HDAC7HDAC8HDAC6HDAC9HDAC5
SCHEMBL28695377 0.73 CA2 (0.37) POLBTAS1R3TAS1R1CTSKCTSS
SCHEMBL5452343 0.72 CYP2D6 (0.30)
SCHEMBL24600056 0.71 ADH1B (0.38) HDAC7HDAC8HDAC6HDAC9HDAC5
SCHEMBL5133204 0.70 TAS1R3 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL10010696 0.70 CHRM1 (0.46) CHRM1AKR1A1CHRM3HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504500-A Synthesis process of propargyl butylcarbamate 安道麦安邦(江苏)有限公司 2025-02-25 CN claimed
US-20210337793-A1 ANTIMICROBIAL MIXTURES COMPRISING AT LEAST ONE HYDROXYPHENONE DERIVATIVE SYMRISE AG (DE) 2021-11-04 US claimed
EP-1581052-A2 AN EMOLLIENT ALCOHOL SKIN DISINFECTING FORMULATION Becton, Dickinson and Company (US) 2005-10-05 EP claimed
WO-2004062589-A2 AN EMOLLIENT ALCOHOL SKIN DISINFECTING FORMULATION BECTON DICKINSON AND COMPANY (US) 2004-07-29 WO claimed
US-20250161202-A1 BIOME-FRIENDLY CONSUMER PRODUCTS AOBIOME LLC (US) 2025-05-22 US disclosed
CN-119504500-A Synthesis process of propargyl butylcarbamate 安道麦安邦(江苏)有限公司 2025-02-25 CN disclosed
US-12193441-B2 Antimicrobial mixtures comprising at least one hydroxyphenone derivative SYMRISE AG (DE) 2025-01-14 US disclosed
US-20240373845-A1 ANTIMICROBIAL MIXTURES COMPRISING AT LEAST ONE HYDROXYPHENONE DERIVATIVE SYMRISE AG (DE) 2024-11-14 US disclosed
US-20240366497-A1 BIOME-FRIENDLY CONSUMER PRODUCTS AOBIOME LLC (US) 2024-11-07 US disclosed
US-20240130960-A1 BIOME-FRIENDLY CONSUMER PRODUCTS ABIOME LLC (US) 2024-04-25 US disclosed
CN-116634871-A Pesticidal compounds and compositions, methods of use and methods of preparation thereof 阿达玛马克西姆有限公司 2023-08-22 CN disclosed
US-20210337793-A1 ANTIMICROBIAL MIXTURES COMPRISING AT LEAST ONE HYDROXYPHENONE DERIVATIVE SYMRISE AG (DE) 2021-11-04 US disclosed
CN-107746741-A A kind of water-soluble synthesis ester type metal working fluid and preparation method thereof 湖北诚祥科技有限公司 2018-03-02 CN disclosed
CN-107019650-A Sunscreen with reduced fabric staining caused by 4- (tert-butyl) -4' -methoxydibenzoylmethane 拜尔斯道夫股份有限公司 2017-08-08 CN disclosed
CN-106560174-A Sunscreen with reduced fabric staining caused by diethylamino hydroxybenzoyl hexyl benzoate 拜尔斯道夫股份有限公司 2017-04-12 CN disclosed
CN-106118834-A A kind of service life length aluminum alloy cutting fluid and preparation method thereof 东莞市科泽润滑油有限公司 2016-11-16 CN disclosed
US-20130310428-A1 THERMO-STABLE, ARSENIC-FREE SYNERGISTIC BIOCIDE CONCENTRATE COMPOSITION FOR POLYMER MATRICES AND PROCESS FOR PREPARING SAME ISP INVESTMENTS INC. (US) 2013-11-21 US disclosed
EP-0819427-B1 Use of 2(3-iodo-2-propynyl)-butylcarbamate in a cosmetic and/or dermatological composition as active ingredient for the treatment of seborrhea OREAL (FR) 2004-05-06 EP disclosed
EP-0819427-A1 Use of 2(3-iodo-2-propynyl)-butylcarbamate in a cosmetic and/or dermatological composition as the actif for the treatment of seborrhea L'OREAL (FR) 1998-01-21 EP disclosed
EP-0556518-B1 Impregnating waterproof composition SHINETSU CHEMICAL CO (JP) 1996-07-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240373845-A1 ANTIMICROBIAL MIXTURES COMPRISING AT LEAST ONE HYDROXYPHENONE DERIVATIVE HPD, GRHPR, ALDH7A1 CHRM1 1390/4885AKR1A1 433/4885CHRM3 2336/4885
US-12193441-B2 Antimicrobial mixtures comprising at least one hydroxyphenone derivative HOGA1, GNPAT, CLPP CHRM1 4455/4885AKR1A1 618/4885CHRM3 4353/4885
US-20210337793-A1 ANTIMICROBIAL MIXTURES COMPRISING AT LEAST ONE HYDROXYPHENONE DERIVATIVE HOGA1, GNPAT, CLPP CHRM1 4455/4885AKR1A1 618/4885CHRM3 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.